-
2
-
-
0018573963
-
Multiple serotonin receptors: Different binding of 3H-5-hydroxytryptamine, 3H-lysergic acid and diethylamide and 3H-spiroperidol
-
Peroutka SJ, Snyder SH. Multiple serotonin receptors: different binding of 3H-5-hydroxytryptamine, 3H-lysergic acid and diethylamide and 3H-spiroperidol. Mol Pharmacol 1979; 16: 687-99
-
(1979)
Mol Pharmacol
, vol.16
, pp. 687-699
-
-
Peroutka, S.J.1
Snyder, S.H.2
-
3
-
-
0022444356
-
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine
-
Bradley P, Engel G, Feniuk W, et al. (nomenclature committee) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 1986; 25: 563-76
-
(1986)
Neuropharmacology
, vol.25
, pp. 563-576
-
-
Bradley, P.1
Engel, G.2
Feniuk, W.3
-
4
-
-
0024463957
-
Effector coupling mechanisms of the cloned 5-HT1A receptor
-
Fargin A, Raymond JR, Regan JW, et al. Effector coupling mechanisms of the cloned 5-HT1A receptor. J Biol Chem 1989; 264: 14848-52
-
(1989)
J Biol Chem
, vol.264
, pp. 14848-14852
-
-
Fargin, A.1
Raymond, J.R.2
Regan, J.W.3
-
5
-
-
0022483616
-
Serotonin receptors in the human brain. I. Characterisation and autoradiographic localization of 5-HT1A recognition sites: Apparent absence of 5-HT1B recognition sites
-
Hover D, Pazos A, Probst A, et al. Serotonin receptors in the human brain. I. Characterisation and autoradiographic localization of 5-HT1A recognition sites: apparent absence of 5-HT1B recognition sites. Brain Res 1988; 376: 85-96.
-
(1988)
Brain Res
, vol.376
, pp. 85-96
-
-
Hover, D.1
Pazos, A.2
Probst, A.3
-
6
-
-
13344280365
-
Classification and nomenclature of 5-HT receptors: A comment on current issues
-
Hover D, Martin GR. Classification and nomenclature of 5-HT receptors: a comment on current issues. Behav Brain Res 1996; 73: 263-8
-
(1996)
Behav Brain Res
, vol.73
, pp. 263-268
-
-
Hover, D.1
Martin, G.R.2
-
8
-
-
0026647938
-
Molecular cloning of a serotonin receptor from human brain (5-HT1E): A fifth 5-HT1-like sub-type
-
McAllister G, Charlesworth A, Snodin C, et al. Molecular cloning of a serotonin receptor from human brain (5-HT1E): a fifth 5-HT1-like sub-type. Proc Natl Acad Sci USA 1992; 89: 5517-21
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 5517-5521
-
-
McAllister, G.1
Charlesworth, A.2
Snodin, C.3
-
9
-
-
0026733324
-
Isolation of a mouse 5-HT1E-like receptor expressed predominantly in the hippocampus
-
Amlaiky N, Ramboz S, Boschert U, et al. Isolation of a mouse 5-HT1E-like receptor expressed predominantly in the hippocampus. J Biol Chem 1992; 92: 19761-4
-
(1992)
J Biol Chem
, vol.92
, pp. 19761-19764
-
-
Amlaiky, N.1
Ramboz, S.2
Boschert, U.3
-
10
-
-
0027534382
-
Cloning of another human serotonin receptor (5-HT1F): A fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase
-
Adham N, Kao H-T, Schlechter L.E, et al. Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc Natl Acad Sci USA 1993; 89: 408-12
-
(1993)
Proc Natl Acad Sci USA
, vol.89
, pp. 408-412
-
-
Adham, N.1
Kao, H.-T.2
Schlechter, L.E.3
-
11
-
-
0011353846
-
Agonists and antagonists at 5-HT receptor subtypes
-
Hoyer D. Agonists and antagonists at 5-HT receptor subtypes. Adv Biosci 1992; 85: 29-47
-
(1992)
Adv Biosci
, vol.85
, pp. 29-47
-
-
Hoyer, D.1
-
12
-
-
0023925856
-
A 5-HT receptor in the nervous system positively coupled with adenylate cyclase is antagonised by ICS 205 930
-
Dumuis A, Boulelal R, Sebben M, et al. A 5-HT receptor in the nervous system positively coupled with adenylate cyclase is antagonised by ICS 205 930. Eur J Pharmacol 1988; 146: 187-8
-
(1988)
Eur J Pharmacol
, vol.146
, pp. 187-188
-
-
Dumuis, A.1
Boulelal, R.2
Sebben, M.3
-
13
-
-
0024466617
-
The gastrointestinal prokinelic benzamide derivatives are agonists at a non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons
-
Dumuis A, Sebben M, Bockaert J. The gastrointestinal prokinelic benzamide derivatives are agonists at a non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons. Naunyn Schmiedebergs Arch Pharamacol 1989; 340: 403-10.
-
(1989)
Naunyn Schmiedebergs Arch Pharamacol
, vol.340
, pp. 403-410
-
-
Dumuis, A.1
Sebben, M.2
Bockaert, J.3
-
14
-
-
7144233713
-
Evidence for a difference in mechanism of the action between fenfluramine and amphetamine induced anorexia
-
Jesperson S, Scheel-Kruger J. Evidence for a difference in mechanism of the action between fenfluramine and amphetamine induced anorexia. J Pharm Pharmacol 1973; 22: 637-8
-
(1973)
J Pharm Pharmacol
, vol.22
, pp. 637-638
-
-
Jesperson, S.1
Scheel-Kruger, J.2
-
15
-
-
0016840631
-
Inhibition of drug-induced anorexia in rats by methysergide
-
Barrett AM, McSherry L. Inhibition of drug-induced anorexia in rats by methysergide. J Pharm Pharmacol 1975; 27: 889-95
-
(1975)
J Pharm Pharmacol
, vol.27
, pp. 889-895
-
-
Barrett, A.M.1
McSherry, L.2
-
16
-
-
0016816599
-
Fenfluramine: A review of the pharmacological properties and therapeutic efficacy in obesity
-
Pinder BM, Brogden RN, Sawyer PR, et al. Fenfluramine: a review of the pharmacological properties and therapeutic efficacy in obesity. Drugs 1975; 10: 241-323
-
(1975)
Drugs
, vol.10
, pp. 241-323
-
-
Pinder, B.M.1
Brogden, R.N.2
Sawyer, P.R.3
-
18
-
-
0015366019
-
Studies on food intake of genetically obese rats
-
Bray GA, York DA. Studies on food intake of genetically obese rats. Am J Physiol 1972; 223: 176-9
-
(1972)
Am J Physiol
, vol.223
, pp. 176-179
-
-
Bray, G.A.1
York, D.A.2
-
19
-
-
0442320794
-
Evidence for the effect of tryptophan on the pattern of food consumption in rats
-
Latham CJ, Blundell JE. Evidence for the effect of tryptophan on the pattern of food consumption in rats. Life Sci 1979; 24: 1271-8
-
(1979)
Life Sci
, vol.24
, pp. 1271-1278
-
-
Latham, C.J.1
Blundell, J.E.2
-
20
-
-
0018569390
-
Serotoninergic influences on food intake: Effect of 5-hydroxytryptophan on parameters of feeding behaviour in deprived and free-feeding rats
-
Blundell JE, Latham CJ. Serotoninergic influences on food intake: effect of 5-hydroxytryptophan on parameters of feeding behaviour in deprived and free-feeding rats. Pharmacol Biochem Behav 1979; 11: 431-7
-
(1979)
Pharmacol Biochem Behav
, vol.11
, pp. 431-437
-
-
Blundell, J.E.1
Latham, C.J.2
-
21
-
-
0018293713
-
Hyperphagia following intraventricular p-chlorophenylalanine-, leucine-or tryptophan-methyl esters: Lack of correlation with whole brain serotonin level
-
MacKenzie RG, Hoebel BG, Ducret RP, et al. Hyperphagia following intraventricular p-chlorophenylalanine-, leucine-or tryptophan-methyl esters: lack of correlation with whole brain serotonin level. Pharmacol Biochem Behav 1979; 10: 951-5
-
(1979)
Pharmacol Biochem Behav
, vol.10
, pp. 951-955
-
-
MacKenzie, R.G.1
Hoebel, B.G.2
Ducret, R.P.3
-
22
-
-
0017563357
-
Is there a role for serotonin (5-hydroxytryptamine) in feeding?
-
Blundell JE. Is there a role for serotonin (5-hydroxytryptamine) in feeding? Int J Obes 1977; 1: 15-42
-
(1977)
Int J Obes
, vol.1
, pp. 15-42
-
-
Blundell, J.E.1
-
23
-
-
0026669497
-
Characterization of the human 5-HT1B receptor
-
Jin H, Oksenberg D, Askenzai A, et al. Characterization of the human 5-HT1B receptor. J Biol Chem 1992; 267 (9): 5735-8
-
(1992)
J Biol Chem
, vol.267
, Issue.9
, pp. 5735-5738
-
-
Jin, H.1
Oksenberg, D.2
Askenzai, A.3
-
24
-
-
0029400158
-
Multiple serotonin receptors: Opportunities for new treatments for obesity
-
Dourish CT. Multiple serotonin receptors: opportunities for new treatments for obesity. Obes Res 1995; 3 Suppl.: 449-62s
-
(1995)
Obes Res
, vol.3
, Issue.SUPPL.
-
-
Dourish, C.T.1
-
25
-
-
0001538488
-
The neuropharmacology of meal patterning
-
Cooper SJ, Hendrie CA, editors. Chichester: Wiley
-
Clifton PG. The neuropharmacology of meal patterning. In: Cooper SJ, Hendrie CA, editors. Ethology and psychopharmacology. Chichester: Wiley, 1994: 313-28
-
(1994)
Ethology and Psychopharmacology
, pp. 313-328
-
-
Clifton, P.G.1
-
26
-
-
0024496216
-
Evidence that d-tenfluramine anorexia is mediated by 5-HT1 receptors
-
Neill JC, Cooper SJ. Evidence that d-tenfluramine anorexia is mediated by 5-HT1 receptors. Psychopharmacology 1989; 97: 213-8
-
(1989)
Psychopharmacology
, vol.97
, pp. 213-218
-
-
Neill, J.C.1
Cooper, S.J.2
-
27
-
-
0024591459
-
Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity of d-fenfluramine in the rat
-
Samanin R, Mennini T, Bendotti C, et al. Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity of d-fenfluramine in the rat. Neuropharmacologv 1989; 28: 465-9
-
(1989)
Neuropharmacologv
, vol.28
, pp. 465-469
-
-
Samanin, R.1
Mennini, T.2
Bendotti, C.3
-
28
-
-
0025052357
-
Studies on the role of 5-HT receptors in satiation and the effect of d-fenfluramine in the runway test
-
Neill JC, Bendotti C, Samanin R. Studies on the role of 5-HT receptors in satiation and the effect of d-fenfluramine in the runway test. Eur J Pharmacol 1990; 190: 105-12
-
(1990)
Eur J Pharmacol
, vol.190
, pp. 105-112
-
-
Neill, J.C.1
Bendotti, C.2
Samanin, R.3
-
29
-
-
0024155157
-
Suppression of food intake in rats by fluoxetine: Comparison of enantiomers and effects of serotonin antagonists
-
Wong DT, Reid LR, Threlkeld PG. Suppression of food intake in rats by fluoxetine: comparison of enantiomers and effects of serotonin antagonists. Pharmacol Biochem Behav 1988; 31: 475-9
-
(1988)
Pharmacol Biochem Behav
, vol.31
, pp. 475-479
-
-
Wong, D.T.1
Reid, L.R.2
Threlkeld, P.G.3
-
30
-
-
0026587480
-
Role of serotonin and catecholamines in brain in feeding suppressant effects of fluoxetine
-
Grignaschi G, Samanin R. Role of serotonin and catecholamines in brain in feeding suppressant effects of fluoxetine. Neuropharmacology 1992; 31: 445-9
-
(1992)
Neuropharmacology
, vol.31
, pp. 445-449
-
-
Grignaschi, G.1
Samanin, R.2
-
31
-
-
0026534847
-
Partial reversal of fluoxetine anorexia by the 5-HT antagonist metergoline
-
Lee MD, Clifton PG. Partial reversal of fluoxetine anorexia by the 5-HT antagonist metergoline. Psychopharmacology 1992; 107: 359-64
-
(1992)
Psychopharmacology
, vol.107
, pp. 359-364
-
-
Lee, M.D.1
Clifton, P.G.2
-
32
-
-
0030218856
-
Metergoline antagonizes fluoxetine-induced suppression of food intake but not changes in the behavioural satiety sequence
-
Halford JCG, Blundell JE. Metergoline antagonizes fluoxetine-induced suppression of food intake but not changes in the behavioural satiety sequence. Pharmacol Biochem Behav 1996; 54: 745-51
-
(1996)
Pharmacol Biochem Behav
, vol.54
, pp. 745-751
-
-
Halford, J.C.G.1
Blundell, J.E.2
-
33
-
-
0031015701
-
Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability
-
Curzon G, Gibson EL, Oluyomi AO. Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. Trends Pharmacol Sci 1997; 18: 21-5
-
(1997)
Trends Pharmacol Sci
, vol.18
, pp. 21-25
-
-
Curzon, G.1
Gibson, E.L.2
Oluyomi, A.O.3
-
34
-
-
0029049224
-
In vitro and in vivo effects of d-fenfluramine: No apparent relation between 5-hydroxytryptamine release and hypophagia
-
Raiteri M, Bonanno G, Vallebouona F. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia. J Pharmacol Exp Ther 1995; 273: 643-9
-
(1995)
J Pharmacol Exp Ther
, vol.273
, pp. 643-649
-
-
Raiteri, M.1
Bonanno, G.2
Vallebouona, F.3
-
35
-
-
0011722654
-
Hypophagic effect of fluoxetine in rats is not mediated by inhibition of 5-HT re-uptake or an agonist action at 5-HT2C receptors
-
Lightowler S, Kennett GA, Wood MD, et al. Hypophagic effect of fluoxetine in rats is not mediated by inhibition of 5-HT re-uptake or an agonist action at 5-HT2C receptors. Br J Pharmacol 1994; 112: 359-64
-
(1994)
Br J Pharmacol
, vol.112
, pp. 359-364
-
-
Lightowler, S.1
Kennett, G.A.2
Wood, M.D.3
-
36
-
-
0020621792
-
Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin
-
Koe BK, Weissman A, Welch WM, et al. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin. J Pharmacol Exp Ther 1983; 266: 686-700
-
(1983)
J Pharmacol Exp Ther
, vol.266
, pp. 686-700
-
-
Koe, B.K.1
Weissman, A.2
Welch, W.M.3
-
37
-
-
0023764826
-
Reduction of feeding behaviour by the serotonin uptake inhibitor sertraline
-
Lucki I, Kreider MS, Simansky KJ. Reduction of feeding behaviour by the serotonin uptake inhibitor sertraline. Psychopharmacology 1988; 96: 289-95
-
(1988)
Psychopharmacology
, vol.96
, pp. 289-295
-
-
Lucki, I.1
Kreider, M.S.2
Simansky, K.J.3
-
38
-
-
0026510184
-
A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: Evidence that dopamine is not a pharmacological target for sibutramine
-
Heal DJ, Frankland ATJ, Gosden J, et al. A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine. Psychopharmacology 1991; 107: 303-9
-
(1991)
Psychopharmacology
, vol.107
, pp. 303-309
-
-
Heal, D.J.1
Frankland, A.T.J.2
Gosden, J.3
-
39
-
-
0030759773
-
Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline re-uptake inhibitor, sibutramine, in the rat
-
Jackson HC, Bearham MC, Hutchins LJ, et al. Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline re-uptake inhibitor, sibutramine, in the rat. Br J Pharmacol 1997; 121: 1613-8
-
(1997)
Br J Pharmacol
, vol.121
, pp. 1613-1618
-
-
Jackson, H.C.1
Bearham, M.C.2
Hutchins, L.J.3
-
40
-
-
0026694080
-
Biochemical and behavioural studies of the 5-HT1B receptor agonist, CP-94,253
-
Koe BK, Nielsen JA, Macor JE, et al. Biochemical and behavioural studies of the 5-HT1B receptor agonist, CP-94,253. Drug Dev Res 1992; 26: 241-50
-
(1992)
Drug Dev Res
, vol.26
, pp. 241-250
-
-
Koe, B.K.1
Nielsen, J.A.2
Macor, J.E.3
-
41
-
-
0030222490
-
The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence
-
Halford JCG, Blundell JE. The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence. Physiol Behav 1996; 60: 933-9
-
(1996)
Physiol Behav
, vol.60
, pp. 933-939
-
-
Halford, J.C.G.1
Blundell, J.E.2
-
42
-
-
0023161869
-
5-HT1B agonists induce anorexia at a post synaptic site
-
Kennett GA, Dourish CT, Curzon G. 5-HT1B agonists induce anorexia at a post synaptic site. Eur J Pharmacol 1987; 141: 429-35
-
(1987)
Eur J Pharmacol
, vol.141
, pp. 429-435
-
-
Kennett, G.A.1
Dourish, C.T.2
Curzon, G.3
-
43
-
-
0001595170
-
Analysing the structure and sequence of feeding in animals and man
-
Christie WM, Weinman J, editors. Chichester: Wiley
-
Blundell JE, Alikhan H. Analysing the structure and sequence of feeding in animals and man. In: Christie WM, Weinman J, editors. Microcomputers, psychology and medicine. Chichester: Wiley, 1990: 203-25
-
(1990)
Microcomputers, Psychology and Medicine
, pp. 203-225
-
-
Blundell, J.E.1
Alikhan, H.2
-
44
-
-
0023894791
-
Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors
-
Kennett GA, Curzon G. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol 1988; 94: 137-47
-
(1988)
Br J Pharmacol
, vol.94
, pp. 137-147
-
-
Kennett, G.A.1
Curzon, G.2
-
45
-
-
0023678368
-
Evidence that the hxpophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors: Hypophagia induced by RU-24969 only requires 5-HT1B receptors
-
Kennett GA, Curzon G. Evidence that the hxpophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors: hypophagia induced by RU-24969 only requires 5-HT1B receptors. Psychopharmacology 1988; 96: 93-100
-
(1988)
Psychopharmacology
, vol.96
, pp. 93-100
-
-
Kennett, G.A.1
Curzon, G.2
-
46
-
-
0025613807
-
Serotonin and appetite
-
Curzon G. Serotonin and appetite. Ann NY Acad Sci 1990; 600: 521-30
-
(1990)
Ann NY Acad Sci
, vol.600
, pp. 521-530
-
-
Curzon, G.1
-
47
-
-
0025949158
-
Effects of tryptophan and 5-hydroxytryptamine receptor subtype agonists on feeding
-
Curzon G. Effects of tryptophan and 5-hydroxytryptamine receptor subtype agonists on feeding. Adv Exp Med Biol 1991; 294: 377-88
-
(1991)
Adv Exp Med Biol
, vol.294
, pp. 377-388
-
-
Curzon, G.1
-
48
-
-
0028300777
-
In vivo properties of SB 200646A, a 5-HT2c/2b receptor antagonist
-
Kennett GA, Wood MD, Glen A, et al. In vivo properties of SB 200646A, a 5-HT2c/2b receptor antagonist. Br J Pharmacol 1994; 111: 797-802
-
(1994)
Br J Pharmacol
, vol.111
, pp. 797-802
-
-
Kennett, G.A.1
Wood, M.D.2
Glen, A.3
-
49
-
-
0018088673
-
A 5-hydroxytryptamine like mode of action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212)
-
Clineschmidt BV, McGuffen JC, Pfleuger AB. A 5-hydroxytryptamine like mode of action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) Br J Pharmacol 1978; 62: 579-89
-
(1978)
Br J Pharmacol
, vol.62
, pp. 579-589
-
-
Clineschmidt, B.V.1
McGuffen, J.C.2
Pfleuger, A.B.3
-
50
-
-
0024434489
-
MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1c receptor subtype
-
King BH, Brazell C, Dourish CT. MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1c receptor subtype. Neurosci Lett 1989; 105: 174-6
-
(1989)
Neurosci Lett
, vol.105
, pp. 174-176
-
-
King, B.H.1
Brazell, C.2
Dourish, C.T.3
-
51
-
-
0028307697
-
1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors
-
Aulakh CS, Mazzola-Pomietto P, Wozniak KM, et al. 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors. J Pharmacol Exp Ther 1994; 270: 127-52
-
(1994)
J Pharmacol Exp Ther
, vol.270
, pp. 127-152
-
-
Aulakh, C.S.1
Mazzola-Pomietto, P.2
Wozniak, K.M.3
-
52
-
-
0029143139
-
Lack of cross tolerance for hypophagia induced by DOI versus mCPP suggests separate mediation by 5-HT2A and 5-HT2c receptors respectively
-
Aulakh CS, Mazzola-Pomietto P, Hulihan-Giblin BA, et al. Lack of cross tolerance for hypophagia induced by DOI versus mCPP suggests separate mediation by 5-HT2A and 5-HT2c receptors respectively. Neuropsychopharmacology 1995; 13: 1-8
-
(1995)
Neuropsychopharmacology
, vol.13
, pp. 1-8
-
-
Aulakh, C.S.1
Mazzola-Pomietto, P.2
Hulihan-Giblin, B.A.3
-
53
-
-
0030636993
-
The 5-HT receptor agonist MK-212 reduces food intake but disrupts the behavioural satiety sequence
-
Halford JCG, Lawton CL, Blundell JE. The 5-HT receptor agonist MK-212 reduces food intake but disrupts the behavioural satiety sequence. Pharmacol Biochem Behav 1997; 56: 41-6
-
(1997)
Pharmacol Biochem Behav
, vol.56
, pp. 41-46
-
-
Halford, J.C.G.1
Lawton, C.L.2
Blundell, J.E.3
-
54
-
-
0025610262
-
Behavioural mechanisms for the anorectic actions of the serotonin (5-HT) uptake inhibitor sertraline in rats: Comparison with directly acting agonists
-
Simansky KJ, Vaidya, AH. Behavioural mechanisms for the anorectic actions of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting agonists. Brain Res Bull 1990; 25: 953-60
-
(1990)
Brain Res Bull
, vol.25
, pp. 953-960
-
-
Simansky, K.J.1
Vaidya, A.H.2
-
55
-
-
0028909857
-
Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors
-
Tecott LH, Sun LM, Akana SF, et al. Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors. Nature 1995; 374 (6522): 542-6
-
(1995)
Nature
, vol.374
, Issue.6522
, pp. 542-546
-
-
Tecott, L.H.1
Sun, L.M.2
Akana, S.F.3
-
56
-
-
0001851089
-
Pharmacological manipulations of feeding behaviour: Possible influences of serotonin and dopamine on food intake
-
Garattini S, Samanin R, editors. New York: Raven Press
-
Blundell JE, Latham CJ. Pharmacological manipulations of feeding behaviour: possible influences of serotonin and dopamine on food intake. In: Garattini S, Samanin R, editors. Central mechanisms of anorectic drugs. New York: Raven Press, 1978: 83-109
-
(1978)
Central Mechanisms of Anorectic Drugs
, pp. 83-109
-
-
Blundell, J.E.1
Latham, C.J.2
-
57
-
-
0018940214
-
Characteristic adjustments to the structure of feeding behaviour following pharmacological treatments: Effects of amphetamine and fenfluramine and the antagonism produced by pimozide and metergoline
-
Blundell JE, Latham CJ. Characteristic adjustments to the structure of feeding behaviour following pharmacological treatments: effects of amphetamine and fenfluramine and the antagonism produced by pimozide and metergoline. Pharmacol Biochem Behav 1980; 12: 717-22
-
(1980)
Pharmacol Biochem Behav
, vol.12
, pp. 717-722
-
-
Blundell, J.E.1
Latham, C.J.2
-
58
-
-
0022383490
-
Behavioural structure and mechanisms of anorexia: Calibration of normal and abnormal inhibition of eating
-
Blundell JE, Rogers PJ, Hill AJ. Behavioural structure and mechanisms of anorexia: calibration of normal and abnormal inhibition of eating. Brain Res Bull 1985; 15: 319-26
-
(1985)
Brain Res Bull
, vol.15
, pp. 319-326
-
-
Blundell, J.E.1
Rogers, P.J.2
Hill, A.J.3
-
59
-
-
0016776704
-
Cholecystokinin elicits the complete behavioural sequence of satiety in rats
-
Antin J, Gibbs J, Holt J, et al. Cholecystokinin elicits the complete behavioural sequence of satiety in rats. J Comp Physiol Psych 1975; 89: 784-60
-
(1975)
J Comp Physiol Psych
, vol.89
, pp. 784-860
-
-
Antin, J.1
Gibbs, J.2
Holt, J.3
-
60
-
-
0002692552
-
Behavioural flux and feeding: Continuous monitoring of food intake and food selection, and the video-recording of appetitive and satiety sequences for the analysis of drug action
-
Samanin R, Garittini S, editors. New York: Raven Press
-
Blundell JE, McArthur RA. Behavioural flux and feeding: continuous monitoring of food intake and food selection, and the video-recording of appetitive and satiety sequences for the analysis of drug action. In: Samanin R, Garittini S, editors. Anorectic agents: mechanisms of action and tolerance. New York: Raven Press, 1981: 19-43
-
(1981)
Anorectic Agents: Mechanisms of Action and Tolerance
, pp. 19-43
-
-
Blundell, J.E.1
McArthur, R.A.2
-
62
-
-
0002015523
-
5-hydroxytrytaminergic drugs compared on the behavioural sequence associated with satiety
-
Halford JCG, Blundell JE. 5-hydroxytrytaminergic drugs compared on the behavioural sequence associated with satiety [abstract]. Br J Pharmacol 1993; 100: 95p
-
(1993)
Br J Pharmacol
, vol.100
-
-
Halford, J.C.G.1
Blundell, J.E.2
-
63
-
-
0023876415
-
Fenfluramine disrupts the behavioural satiety sequence in rats
-
Montgomery AMJ, Willner P. Fenfluramine disrupts the behavioural satiety sequence in rats. Psychopharmacology 1988; 94: 397-401
-
(1988)
Psychopharmacology
, vol.94
, pp. 397-401
-
-
Montgomery, A.M.J.1
Willner, P.2
-
64
-
-
0025105694
-
Behavioural analysis of the anorectic effects of fluoxetine and fenfluramine
-
Willner P, McGuirk J, Phillips G, et al. Behavioural analysis of the anorectic effects of fluoxetine and fenfluramine. Psychopharmacology 1990; 102: 273-7
-
(1990)
Psychopharmacology
, vol.102
, pp. 273-277
-
-
Willner, P.1
McGuirk, J.2
Phillips, G.3
-
65
-
-
0026611434
-
Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence
-
McGuirk J, Muscat R, Willner P. Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence. Psychopharmacology 1992; 107: 401-7
-
(1992)
Psychopharmacology
, vol.107
, pp. 401-407
-
-
McGuirk, J.1
Muscat, R.2
Willner, P.3
-
66
-
-
0026555904
-
Effects of the 5-HT uptake inhibitors femoxitine and paroxetine, and the 5-HT1A agonist citalopram, on the behavioural satiety sequence
-
McGuirk J, Muscat R, Willner P. Effects of the 5-HT uptake inhibitors femoxitine and paroxetine, and the 5-HT1A agonist citalopram, on the behavioural satiety sequence. Pharmacol Biochem Behav 1992; 41: 801-5
-
(1992)
Pharmacol Biochem Behav
, vol.41
, pp. 801-805
-
-
McGuirk, J.1
Muscat, R.2
Willner, P.3
-
67
-
-
0001612783
-
Effects in the rat of sibutramine on food intake and the behavioural satiety sequence
-
Halford JCG, Heal DJ, Blundell JE. Effects in the rat of sibutramine on food intake and the behavioural satiety sequence [abstract]. Br J Pharmacol 1995; 114: 378p
-
(1995)
Br J Pharmacol
, vol.114
-
-
Halford, J.C.G.1
Heal, D.J.2
Blundell, J.E.3
-
68
-
-
0028298214
-
An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats
-
Kitchener SJ, Dourish CT. An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats. Psychopharmacology 1994; 113: 369-77
-
(1994)
Psychopharmacology
, vol.113
, pp. 369-377
-
-
Kitchener, S.J.1
Dourish, C.T.2
-
69
-
-
0026516805
-
CCK antagonists and CCK-monoamine interactions in the control of satiety
-
Cooper SJ, Dourish CT, Clifton PG. CCK antagonists and CCK-monoamine interactions in the control of satiety. Am J Clin Nutr 1992; 55 Suppl.: 291s-295s
-
(1992)
Am J Clin Nutr
, vol.55
, Issue.SUPPL.
-
-
Cooper, S.J.1
Dourish, C.T.2
Clifton, P.G.3
-
70
-
-
0027299411
-
Reciprocal interaction of 5-hydroxytryptamine and cholecystokinin in the control of feeding
-
Grignaschi G, Mantelli B, Fracasso C, et al. Reciprocal interaction of 5-hydroxytryptamine and cholecystokinin in the control of feeding. Br J Pharmacol 1993; 109 (2): 491-4
-
(1993)
Br J Pharmacol
, vol.109
, Issue.2
, pp. 491-494
-
-
Grignaschi, G.1
Mantelli, B.2
Fracasso, C.3
-
71
-
-
0028988108
-
Evidence for the involvement of the 5-HT1A receptor in CCK-induced satiety in rats
-
Voigt JP, Fink H, Marsden CA. Evidence for the involvement of the 5-HT1A receptor in CCK-induced satiety in rats. Naunyn Schmiedebergs Arch Pharmacol 1995; 351: 217-20
-
(1995)
Naunyn Schmiedebergs Arch Pharmacol
, vol.351
, pp. 217-220
-
-
Voigt, J.P.1
Fink, H.2
Marsden, C.A.3
-
72
-
-
0027398306
-
Cholecystokinin-induced satiety depends on the activation of 5-HT1C receptors
-
Poeschla B, Gibbs J, Simansky KJ, et al. Cholecystokinin-induced satiety depends on the activation of 5-HT1C receptors. Am J Physiol 1993; 264: R62-4
-
(1993)
Am J Physiol
, vol.264
-
-
Poeschla, B.1
Gibbs, J.2
Simansky, K.J.3
-
73
-
-
0026611486
-
The 5-HT1A agonist 8-OH-DPAT attenuated the satiating action of cholecystokinin
-
Poeschla B, Gibbs J, Simansky KJ, et al. The 5-HT1A agonist 8-OH-DPAT attenuated the satiating action of cholecystokinin. Pharmacol Biochem Behav 1992; 42: 541-3
-
(1992)
Pharmacol Biochem Behav
, vol.42
, pp. 541-543
-
-
Poeschla, B.1
Gibbs, J.2
Simansky, K.J.3
-
74
-
-
0025280635
-
3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3.2-b]pyrid-5-one: A potent and selective 5-HT1B agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyid-4-yl)indole
-
Macor JE, Burkhart CA, Heym JH, et al. 3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3.2-b]pyrid-5-one: a potent and selective 5-HT1B agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyid-4-yl)indole. J Med Chem 1990; 33: 2087-93
-
(1990)
J Med Chem
, vol.33
, pp. 2087-2093
-
-
Macor, J.E.1
Burkhart, C.A.2
Heym, J.H.3
-
75
-
-
0028985410
-
The 5-HT1B receptor mediates the effect of d-fenfluramine on eating caused by intrahypothalamic injection of neuropeptide Y
-
Grignaschi G, Sironi F, Samanin R. The 5-HT1B receptor mediates the effect of d-fenfluramine on eating caused by intrahypothalamic injection of neuropeptide Y. Eur J Pharmacol 1995; 274: 221-4
-
(1995)
Eur J Pharmacol
, vol.274
, pp. 221-224
-
-
Grignaschi, G.1
Sironi, F.2
Samanin, R.3
-
76
-
-
0028847195
-
The serotonin (5-HT) antagonist methysergide increases neuropeptide Y (NPY) synthesis and secretion in the hypothalamus of the rat
-
Dryden S, Wang Q, Krankish HM, et al. The serotonin (5-HT) antagonist methysergide increases neuropeptide Y (NPY) synthesis and secretion in the hypothalamus of the rat. Brain Res 1995; 699: 12-8
-
(1995)
Brain Res
, vol.699
, pp. 12-18
-
-
Dryden, S.1
Wang, Q.2
Krankish, H.M.3
-
77
-
-
0030591469
-
Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine
-
Dryden S, Frankish HM, Wang Q, et al. Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine. Brain Res 1996; 724: 232-7
-
(1996)
Brain Res
, vol.724
, pp. 232-237
-
-
Dryden, S.1
Frankish, H.M.2
Wang, Q.3
-
78
-
-
0029985448
-
The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats
-
Dryden S, Prankish HM, Wang Q, et al. The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats. Neuroscience 1996; 72: 557-66
-
(1996)
Neuroscience
, vol.72
, pp. 557-566
-
-
Dryden, S.1
Prankish, H.M.2
Wang, Q.3
-
79
-
-
0023719763
-
Infusion of the 5-hydroxytryptamine agonists RU-24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia
-
Hutson PH, Donohoe TP, Curzon G. Infusion of the 5-hydroxytryptamine agonists RU-24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology 1988; 97: 550-2
-
(1988)
Psychopharmacology
, vol.97
, pp. 550-552
-
-
Hutson, P.H.1
Donohoe, T.P.2
Curzon, G.3
-
80
-
-
0027421365
-
Injecting 5-HT into the PVN does not prevent feeding induced by 8-OH-DPAT into the raphe
-
Fletcher PJ, Coscina DV. Injecting 5-HT into the PVN does not prevent feeding induced by 8-OH-DPAT into the raphe. Pharmacol Biochem Behav 1993; 46: 487-91
-
(1993)
Pharmacol Biochem Behav
, vol.46
, pp. 487-491
-
-
Fletcher, P.J.1
Coscina, D.V.2
-
81
-
-
0028289642
-
Intra-ventricular but not intra-paraventricular nucleus metergoline elicits feeding in satiated rats
-
Coscina DV, Feifel D, Nobrega JN, et al. Intra-ventricular but not intra-paraventricular nucleus metergoline elicits feeding in satiated rats. Am J Physiol 1994); 266: r1562-7
-
(1994)
Am J Physiol
, vol.266
-
-
Coscina, D.V.1
Feifel, D.2
Nobrega, J.N.3
-
82
-
-
0029968883
-
Metergoline potentiates natural feeding and antagonizes the anorectic action of medial hypothalamic 5-HT
-
Currie PJ, Coscina DV. Metergoline potentiates natural feeding and antagonizes the anorectic action of medial hypothalamic 5-HT. Pharmacol Biochem Behav 1996; 53: 1023-8
-
(1996)
Pharmacol Biochem Behav
, vol.53
, pp. 1023-1028
-
-
Currie, P.J.1
Coscina, D.V.2
-
83
-
-
0001874278
-
The role of hypothalamic peptides in the control of energy balance and body weight
-
Dryden S, Williams G. The role of hypothalamic peptides in the control of energy balance and body weight. Curr Opin Endocrinol Diabetes 1996; 3: 51-8
-
(1996)
Curr Opin Endocrinol Diabetes
, vol.3
, pp. 51-58
-
-
Dryden, S.1
Williams, G.2
-
84
-
-
0028048885
-
The importance of 5-hydroxytryptamine receptors in the gut
-
Read NW, Gwee KA. The importance of 5-hydroxytryptamine receptors in the gut. Pharmacol Ther 1994; 62: 159-73
-
(1994)
Pharmacol Ther
, vol.62
, pp. 159-173
-
-
Read, N.W.1
Gwee, K.A.2
-
85
-
-
0028900628
-
Comparisons between the effects of 5-HT and dl-fenfluramine on food intake and gastric emptying in the rat
-
Francis J, Critchley D, Dourish CT, et al. Comparisons between the effects of 5-HT and dl-fenfluramine on food intake and gastric emptying in the rat. Pharmacol Biochem Behav 1995; 50: 581-5
-
(1995)
Pharmacol Biochem Behav
, vol.50
, pp. 581-585
-
-
Francis, J.1
Critchley, D.2
Dourish, C.T.3
-
86
-
-
0026015104
-
Peripherally administered 5-hydroxytryptamine elicits the full behavioural satiety sequence
-
Edwards S, Stevens R. Peripherally administered 5-hydroxytryptamine elicits the full behavioural satiety sequence. Physiol Behav 1991; 50: 1075-7
-
(1991)
Physiol Behav
, vol.50
, pp. 1075-1077
-
-
Edwards, S.1
Stevens, R.2
-
87
-
-
7144227374
-
Serotoninergic control of the organization of feeding and satiety
-
Simansky KJ. Serotoninergic control of the organization of feeding and satiety. Behav Brain Res 1996; 73: 37-42
-
(1996)
Behav Brain Res
, vol.73
, pp. 37-42
-
-
Simansky, K.J.1
-
88
-
-
0029914533
-
Energy density and its role in the control of food intake: Evidence from metabolic and community studies
-
Poppitt SD, Prentice AM. Energy density and its role in the control of food intake: evidence from metabolic and community studies. Appetite 1996; 26: 153-74
-
(1996)
Appetite
, vol.26
, pp. 153-174
-
-
Poppitt, S.D.1
Prentice, A.M.2
-
89
-
-
0029813438
-
High and low fat consumers, their macronutrient intake and body mass index: Further analysis of the National Diet and Nutrition Survey of British adults
-
MacDiaramid JI, Cade JE, Blundell JE. High and low fat consumers, their macronutrient intake and body mass index: further analysis of the National Diet and Nutrition Survey of British adults. Eur J Clin Nutr 1997; 50 (8): 505-12
-
(1997)
Eur J Clin Nutr
, vol.50
, Issue.8
, pp. 505-512
-
-
MacDiaramid, J.I.1
Cade, J.E.2
Blundell, J.E.3
-
90
-
-
0029031491
-
Fat and carbohydrate overfeeding in humans: Different effects on energy storage
-
Horton TJ, Drougas H, Brachey A, et al. Fat and carbohydrate overfeeding in humans: different effects on energy storage. Am J Clin Nutr 1995; 62: 19-29
-
(1995)
Am J Clin Nutr
, vol.62
, pp. 19-29
-
-
Horton, T.J.1
Drougas, H.2
Brachey, A.3
-
91
-
-
7144238319
-
Control of brain 5-HT content by dietary carbohydrates
-
Barchas J, Usdin E, editors. New York: Academic Press
-
Fernstrom JD, Wurtman RJ. Control of brain 5-HT content by dietary carbohydrates. In: Barchas J, Usdin E, editors. Serotonin and behaviour. New York: Academic Press, 1973: 121-8
-
(1973)
Serotonin and Behaviour
, pp. 121-128
-
-
Fernstrom, J.D.1
Wurtman, R.J.2
-
92
-
-
0016136716
-
Effects of diet on brain neurotransmitters
-
Wurtman RJ, Fernstrom JD. Effects of diet on brain neurotransmitters. Nutr Rev 1974; 32: 193-200
-
(1974)
Nutr Rev
, vol.32
, pp. 193-200
-
-
Wurtman, R.J.1
Fernstrom, J.D.2
-
93
-
-
0024819055
-
The effect of protein or carbohydrate breakfasts on subsequent plasma amino acid levels, satiety and nutrient selection in normal males
-
Teff KL, Young SN, Blundell JE. The effect of protein or carbohydrate breakfasts on subsequent plasma amino acid levels, satiety and nutrient selection in normal males. Pharmacol Biochem Behav 1989; 34: 410-7
-
(1989)
Pharmacol Biochem Behav
, vol.34
, pp. 410-417
-
-
Teff, K.L.1
Young, S.N.2
Blundell, J.E.3
-
94
-
-
0023355378
-
Nutrition, serotonin and appetite: Case studying the evolution of a scientific idea
-
Blundell JE, Hill AJ. Nutrition, serotonin and appetite: case studying the evolution of a scientific idea. Appetite 1987; 8: 183-94
-
(1987)
Appetite
, vol.8
, pp. 183-194
-
-
Blundell, J.E.1
Hill, A.J.2
-
95
-
-
1642463095
-
Effect of diet composition on affective state in anorexia nervosa and hulimia
-
Pirke KM, Schweiger U, Laessle RG. Effect of diet composition on affective state in anorexia nervosa and hulimia. Clin Neuropharmacol 1986; 9: 513-5
-
(1986)
Clin Neuropharmacol
, vol.9
, pp. 513-515
-
-
Pirke, K.M.1
Schweiger, U.2
Laessle, R.G.3
-
96
-
-
0022366113
-
Evidence for diminished brain 5-HT biosynthesis in obese diabetic and non-diabetic humans
-
Ashley DVM, Fleury MO, Golay A, et al. Evidence for diminished brain 5-HT biosynthesis in obese diabetic and non-diabetic humans. Am J Clin Nutr 1985; 42: 1240-5
-
(1985)
Am J Clin Nutr
, vol.42
, pp. 1240-1245
-
-
Ashley, D.V.M.1
Fleury, M.O.2
Golay, A.3
-
97
-
-
0028892925
-
Toward a unified theory of serotonin dysregulation in eating and related disorders
-
Brewerton TD. Toward a unified theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinology 1995; 20: 561-90
-
(1995)
Psychoneuroendocrinology
, vol.20
, pp. 561-590
-
-
Brewerton, T.D.1
-
98
-
-
0023641220
-
Dieting changes 5-HT function in women, not in men: Implications for the aetiology of anorexia nervosa?
-
Goodwin GM, Fairburn CG, Cowen PJ. Dieting changes 5-HT function in women, not in men: implications for the aetiology of anorexia nervosa? Psychol Med 1987; 17: 839-42
-
(1987)
Psychol Med
, vol.17
, pp. 839-842
-
-
Goodwin, G.M.1
Fairburn, C.G.2
Cowen, P.J.3
-
99
-
-
0025311843
-
Plasma concentrations of tryptophan and dieting
-
Goodwin GM, Cowen PJ, Fairburn CJ, et al. Plasma concentrations of tryptophan and dieting. BMJ 1990; 300: 1499-500
-
(1990)
BMJ
, vol.300
, pp. 1499-1500
-
-
Goodwin, G.M.1
Cowen, P.J.2
Fairburn, C.J.3
-
100
-
-
0000404006
-
Problems and processes underlying the control of food selection and nutrient intake
-
Wurtman RJ, Wurtman JJ, editors. New York: Raven Press
-
Blundell JE. Problems and processes underlying the control of food selection and nutrient intake. In: Wurtman RJ, Wurtman JJ, editors. Nutrition and the brain. Vol 6. New York: Raven Press, 1983: 163-222
-
(1983)
Nutrition and the Brain
, vol.6
, pp. 163-222
-
-
Blundell, J.E.1
-
101
-
-
0025285884
-
Food intake and selection pattern of rats treated with dexfenfluramine, fluoxetine and RU-24969
-
Luo S, Li ETS. Food intake and selection pattern of rats treated with dexfenfluramine, fluoxetine and RU-24969. Brain Res Bull 1990; 24: 729-33
-
(1990)
Brain Res Bull
, vol.24
, pp. 729-733
-
-
Luo, S.1
Li, E.T.S.2
-
102
-
-
0026495413
-
The effects of d-fenfluramine on intake of carhohydrate supplements is influenced by the hydration of the test diets
-
Lawton CL, Blundell JE. The effects of d-fenfluramine on intake of carhohydrate supplements is influenced by the hydration of the test diets. Physiol Behav 1992; 3: 517-23
-
(1992)
Physiol Behav
, vol.3
, pp. 517-523
-
-
Lawton, C.L.1
Blundell, J.E.2
-
103
-
-
0027281675
-
5-HT manipulation and dietary choice: Variable carbohydrate (polycose) suppression demonstrated only under specific experimental conditions
-
Lawton CL, Blundell JE. 5-HT manipulation and dietary choice: variable carbohydrate (polycose) suppression demonstrated only under specific experimental conditions. Psychopharmacology 1993; 112: 375-82
-
(1993)
Psychopharmacology
, vol.112
, pp. 375-382
-
-
Lawton, C.L.1
Blundell, J.E.2
-
104
-
-
7144240994
-
Serotonin administration selectively reduces fat intake in rats
-
Kanarek RB, Dushkin H. Serotonin administration selectively reduces fat intake in rats. Pharmacol Biochem Behav 1988; 13: 133-22
-
(1988)
Pharmacol Biochem Behav
, vol.13
, pp. 133-222
-
-
Kanarek, R.B.1
Dushkin, H.2
-
105
-
-
0022500886
-
Brain serotonin and eating behaviour
-
Leibowitz SF, Shor-Posner G. Brain serotonin and eating behaviour. Appetite 1986; 7: 1-14
-
(1986)
Appetite
, vol.7
, pp. 1-14
-
-
Leibowitz, S.F.1
Shor-Posner, G.2
-
106
-
-
0021736711
-
Meal patterns and food selection during the development of obesity in rats fed a cafeteria diet
-
Rogers PJ, Blundell JE. Meal patterns and food selection during the development of obesity in rats fed a cafeteria diet. Neurosci Biobehav Rev 1984; 8: 441-53
-
(1984)
Neurosci Biobehav Rev
, vol.8
, pp. 441-453
-
-
Rogers, P.J.1
Blundell, J.E.2
-
107
-
-
0021705710
-
Animal models of obesity: Classification and characterisation
-
Sclafani A. Animal models of obesity: classification and characterisation. Int J Obes 1984; 8: 491-508
-
(1984)
Int J Obes
, vol.8
, pp. 491-508
-
-
Sclafani, A.1
-
108
-
-
7144244721
-
Energy intake of rats fed a cafeteria diet
-
Prats E, Monfar M, Castella J, et al. Energy intake of rats fed a cafeteria diet. Physiol Behav 1989; 45: 2263-72
-
(1989)
Physiol Behav
, vol.45
, pp. 2263-2272
-
-
Prats, E.1
Monfar, M.2
Castella, J.3
-
109
-
-
0039625220
-
Effects of dexfenfluramine in feeding and body weight: Relationship with food consumption and palatability
-
Vague J, Guy-Grand B, Bjontroup P, editors. Nordlolland: Elsevier
-
Blundell JE, Hill AJ. Effects of dexfenfluramine in feeding and body weight: relationship with food consumption and palatability. In: Vague J, Guy-Grand B, Bjontroup P, editors. Metabolic complication of human obesities. Nordlolland: Elsevier, 1985: 199-206
-
(1985)
Metabolic Complication of Human Obesities
, pp. 199-206
-
-
Blundell, J.E.1
Hill, A.J.2
-
111
-
-
0024164562
-
Do serotoninergic drugs decrease energy intake by reducing fat or carbohydrate intake? Effect of d-fenfluramine with supplemented weight increase diets
-
Blundell JE, Hill AJ. Do serotoninergic drugs decrease energy intake by reducing fat or carbohydrate intake? Effect of d-fenfluramine with supplemented weight increase diets. Pharmacol Biochem Behav 1989; 31: 773-8
-
(1989)
Pharmacol Biochem Behav
, vol.31
, pp. 773-778
-
-
Blundell, J.E.1
Hill, A.J.2
-
112
-
-
0029400216
-
Serotonin, eating behaviour and fat intake
-
Blundell JE, Lawton CL, Halford JCG. Serotonin, eating behaviour and fat intake. Obes Res 1995; 3 Suppl. 4: 471-6
-
(1995)
Obes Res
, vol.3
, Issue.4 SUPPL.
, pp. 471-476
-
-
Blundell, J.E.1
Lawton, C.L.2
Halford, J.C.G.3
-
113
-
-
0343912960
-
Model system for investigating the actions of anorectic drugs: Effects of d-fenfluramine on food intake, nutrient selection, food preferences, meal patterns, hunger and satiety in healthy human subjects
-
Oxford: Pergamon Press
-
Hill AJ, Blundell JE. Model system for investigating the actions of anorectic drugs: effects of d-fenfluramine on food intake, nutrient selection, food preferences, meal patterns, hunger and satiety in healthy human subjects. Advances in the biosciences. Oxford: Pergamon Press, 1986: 377-89
-
(1986)
Advances in the Biosciences
, pp. 377-389
-
-
Hill, A.J.1
Blundell, J.E.2
-
114
-
-
0024213018
-
Differential effect of d-fenfluramine and metergoline on food intake in human subjects
-
Goodall EM, Silverstone T. Differential effect of d-fenfluramine and metergoline on food intake in human subjects. Appetite 1988; 11: 215-8
-
(1988)
Appetite
, vol.11
, pp. 215-218
-
-
Goodall, E.M.1
Silverstone, T.2
-
115
-
-
0023769815
-
On the mechanism of action of dexfenfluramine: Effect on alliesthesia and appetite motivation in lean and obese subjects
-
Blundell JE, Hill AJ. On the mechanism of action of dexfenfluramine: effect on alliesthesia and appetite motivation in lean and obese subjects. Clin Neuropharmacol 1988; 11 Suppl. 1: 121S-34S
-
(1988)
Clin Neuropharmacol
, vol.11
, Issue.1 SUPPL.
-
-
Blundell, J.E.1
Hill, A.J.2
-
116
-
-
0025355281
-
Sensitivity of the appetite control system in obese subjects to nutritional and serotoninergic challenges
-
Hill AJ, Blundell JE. Sensitivity of the appetite control system in obese subjects to nutritional and serotoninergic challenges. Int J Obes 1990; 14: 219-33
-
(1990)
Int J Obes
, vol.14
, pp. 219-233
-
-
Hill, A.J.1
Blundell, J.E.2
-
117
-
-
0029032626
-
Techniques for the experimental measurement of human eating behaviour: A practical guide
-
Hill AJ, Rogers PJ, Blundell JE. Techniques for the experimental measurement of human eating behaviour: a practical guide. Int J Obes 1995; 19: 361-75
-
(1995)
Int J Obes
, vol.19
, pp. 361-375
-
-
Hill, A.J.1
Rogers, P.J.2
Blundell, J.E.3
-
118
-
-
0029330841
-
Serotoninergic manipulation, meal-induced satiety and eating pattern: Effects of fluoxeline in obese female subjects
-
Lawton CL, Wales JK, Hill AJ, et al. Serotoninergic manipulation, meal-induced satiety and eating pattern: effects of fluoxeline in obese female subjects. Obes Res 1995; 3: 345-56
-
(1995)
Obes Res
, vol.3
, pp. 345-356
-
-
Lawton, C.L.1
Wales, J.K.2
Hill, A.J.3
-
119
-
-
0031602176
-
Sibutramine reduces food intake in non-dieting women with obesity
-
Rolls BJ, Shide DJ, Thorwart ML, et al. Sibutramine reduces food intake in non-dieting women with obesity. Obes Res 1998; 6: 1-11
-
(1998)
Obes Res
, vol.6
, pp. 1-11
-
-
Rolls, B.J.1
Shide, D.J.2
Thorwart, M.L.3
-
120
-
-
7144219914
-
Moderate dieting causes 5-HT2C supersensitization
-
Cowen PJ, Clifford EM, Walsh AE, et al. Moderate dieting causes 5-HT2C supersensitization. Psychol Med 1996; 26: 1156-9
-
(1996)
Psychol Med
, vol.26
, pp. 1156-1159
-
-
Cowen, P.J.1
Clifford, E.M.2
Walsh, A.E.3
-
121
-
-
0026446889
-
Eating behaviour and adherence to dietary prescription in obese adult subjects treated with 5-hydroxytryptophan
-
Cangiano C, Ceci F, Casinco A, et al. Eating behaviour and adherence to dietary prescription in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin Nutr 1992; 56: 863-7
-
(1992)
Am J Clin Nutr
, vol.56
, pp. 863-867
-
-
Cangiano, C.1
Ceci, F.2
Casinco, A.3
-
122
-
-
0029402012
-
Sertraline and relapse prevention following treatment by a very low calorie diet: A controlled clinical trial
-
Wadden TA, Bartlett SJ, Foster GD, et al. Sertraline and relapse prevention following treatment by a very low calorie diet: a controlled clinical trial. Obes Res 1995; 3 (6): 549-7
-
(1995)
Obes Res
, vol.3
, Issue.6
, pp. 549-557
-
-
Wadden, T.A.1
Bartlett, S.J.2
Foster, G.D.3
-
123
-
-
0021607738
-
The clinical pharmacology of appetite suppressant drugs
-
Silverstone T, Goodall E. The clinical pharmacology of appetite suppressant drugs. Int J Obes 1984; 8 (1): 23-33
-
(1984)
Int J Obes
, vol.8
, Issue.1
, pp. 23-33
-
-
Silverstone, T.1
Goodall, E.2
-
124
-
-
0018627511
-
Effect of anorexic drugs on food intake and the micro-structure of eating in human subjects
-
Rogers PJ, Blundell JE. Effect of anorexic drugs on food intake and the micro-structure of eating in human subjects. Psychopharmacology 1979; 66: 159-65
-
(1979)
Psychopharmacology
, vol.66
, pp. 159-165
-
-
Rogers, P.J.1
Blundell, J.E.2
-
125
-
-
85005297514
-
Carbohydrate craving in obese people: Suppression by treatments affecting serotoninergic transmission
-
Wurtman JJ, Wurtmann RJ, Growdon JH, et al. Carbohydrate craving in obese people: suppression by treatments affecting serotoninergic transmission. Int J Eat Disord 1982; 1: 2-15
-
(1982)
Int J Eat Disord
, vol.1
, pp. 2-15
-
-
Wurtman, J.J.1
Wurtmann, R.J.2
Growdon, J.H.3
-
126
-
-
0021923986
-
d-Fenfluramine selectively suppresses carbohydrate snacking in obese subjects
-
Wurtman JJ, Wurtman RJ, Mark S, et al. d-Fenfluramine selectively suppresses carbohydrate snacking in obese subjects. Int J Eat Disord 1985; 4: 89-99
-
(1985)
Int J Eat Disord
, vol.4
, pp. 89-99
-
-
Wurtman, J.J.1
Wurtman, R.J.2
Mark, S.3
-
127
-
-
0027360166
-
Ritanserin attenuates anorectic endocrine and thermic responses to d-fenfluramine in human volunteers
-
Goodall EM, Cowen PJ, Franklin M, et al. Ritanserin attenuates anorectic endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacology 1993; 112: 461-6
-
(1993)
Psychopharmacology
, vol.112
, pp. 461-466
-
-
Goodall, E.M.1
Cowen, P.J.2
Franklin, M.3
-
128
-
-
0025329192
-
The effect of 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects
-
McGuirk J, Silverstone T. The effect of 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects. Int J Obes 1990; 14: 361-72
-
(1990)
Int J Obes
, vol.14
, pp. 361-372
-
-
McGuirk, J.1
Silverstone, T.2
-
129
-
-
0028024209
-
m-Chlorophenylpiperazine decreases food intake in a test meal
-
Walsh AE, Smith KA, Oldman AD, et al. m-Chlorophenylpiperazine decreases food intake in a test meal. Psychopharmacology 1994; 116: 120-2
-
(1994)
Psychopharmacology
, vol.116
, pp. 120-122
-
-
Walsh, A.E.1
Smith, K.A.2
Oldman, A.D.3
-
130
-
-
0030609003
-
5-HT2C activation decreases appetite and body weight in obese subjects
-
Sargent PA, Sharpley AL, Williams C, et al. 5-HT2C activation decreases appetite and body weight in obese subjects. Psychopharmacology 1997; 133: 309-12
-
(1997)
Psychopharmacology
, vol.133
, pp. 309-312
-
-
Sargent, P.A.1
Sharpley, A.L.2
Williams, C.3
-
131
-
-
0031016859
-
Sumatriptan decreases food intake and increases plasma growth hormone in women
-
Boeles S, Williams C, Campling GM, et al. Sumatriptan decreases food intake and increases plasma growth hormone in women. Psychopharmacology 1997; 129: 179-82
-
(1997)
Psychopharmacology
, vol.129
, pp. 179-182
-
-
Boeles, S.1
Williams, C.2
Campling, G.M.3
-
132
-
-
0026557374
-
Clinical studies with d-fenfluramine
-
Guy-Grand B. Clinical studies with d-fenfluramine. Am J Clin Nutr 1992; 55 Suppl.: 173s-176s
-
(1992)
Am J Clin Nutr
, vol.55
, Issue.SUPPL.
-
-
Guy-Grand, B.1
-
133
-
-
0026776898
-
Drug therapy after very-low-caloric diets
-
Finer N, Finer S, Nauova RP. Drug therapy after very-low-caloric diets. Am J Clin Nutr 1992; 56: 1955-85
-
(1992)
Am J Clin Nutr
, vol.56
, pp. 1955-1985
-
-
Finer, N.1
Finer, S.2
Nauova, R.P.3
-
134
-
-
0025666806
-
Dieting reduces plasma tryptophan and alters brain 5-HT functioning in women
-
Anderson IM, Parry-Billings M, Newsholme EA, et al. Dieting reduces plasma tryptophan and alters brain 5-HT functioning in women. Psychol Med 1990; 20: 785-91
-
(1990)
Psychol Med
, vol.20
, pp. 785-791
-
-
Anderson, I.M.1
Parry-Billings, M.2
Newsholme, E.A.3
-
135
-
-
0025938842
-
Sibutramine in weight control: A dose-ranging, efficacy study
-
Weintraub M, Rubio A, Golik A, et al. Sibutramine in weight control: a dose-ranging, efficacy study. Clin Pharmacol Ther 1997; 50 (3): 330-7
-
(1997)
Clin Pharmacol Ther
, vol.50
, Issue.3
, pp. 330-337
-
-
Weintraub, M.1
Rubio, A.2
Golik, A.3
-
136
-
-
0030147221
-
A double-blind randomized placebo-controlled trial of sibutramine
-
Bray GA, Ryan DH, Grodon D, et al. A double-blind randomized placebo-controlled trial of sibutramine. Obes Res 1996; 4 (3): 263-70
-
(1996)
Obes Res
, vol.4
, Issue.3
, pp. 263-270
-
-
Bray, G.A.1
Ryan, D.H.2
Grodon, D.3
-
137
-
-
7144249179
-
Sibutramine predictability of long term weight loss
-
Smith I, Fitchet M, Kelly F. Sibutramine predictability of long term weight loss. Int J Obes 1997; 21 Suppl. 2; s53
-
(1997)
Int J Obes
, vol.21
, Issue.2 SUPPL.
-
-
Smith, I.1
Fitchet, M.2
Kelly, F.3
-
138
-
-
0028800705
-
Serotonin and dietary fat intake: Effect of dexfenfluramine
-
Blundell JE, Lawton CL. Serotonin and dietary fat intake: effect of dexfenfluramine. Metabol Clin Exper 1995; 44 (2): 33-7
-
(1995)
Metabol Clin Exper
, vol.44
, Issue.2
, pp. 33-37
-
-
Blundell, J.E.1
Lawton, C.L.2
-
139
-
-
0023433843
-
Changes in mood after carbohydrate consumption
-
Drewnowski A. Changes in mood after carbohydrate consumption [abstract]. Am J Clin Nutr 1987; 46: 703
-
(1987)
Am J Clin Nutr
, vol.46
, pp. 703
-
-
Drewnowski, A.1
-
140
-
-
0027460665
-
Effects of dexfenfluramine treatment on body wight and postprandial thermogenesis in obese subjects: A double-blind, placebo-controlled study
-
Lafreniere F, Lambert J, Rasio E, et al. Effects of dexfenfluramine treatment on body wight and postprandial thermogenesis in obese subjects: a double-blind, placebo-controlled study. Int J Obes 1993; 17: 25-30
-
(1993)
Int J Obes
, vol.17
, pp. 25-30
-
-
Lafreniere, F.1
Lambert, J.2
Rasio, E.3
-
141
-
-
0001566450
-
The effect of dexfenfluramine on energy and macronutrient balance of obese women on high fat and low fat diets
-
Poppitt SD, Murgatroyd PR, Tainsh KR, et al. The effect of dexfenfluramine on energy and macronutrient balance of obese women on high fat and low fat diets [abstract]. Int J Obes 1997; 21 Suppl. 2: s65
-
(1997)
Int J Obes
, vol.21
, Issue.2 SUPPL.
-
-
Poppitt, S.D.1
Murgatroyd, P.R.2
Tainsh, K.R.3
-
142
-
-
1642415808
-
Risk factors for overeating: Dexfenfluramine suppresses the intake of sweet high fat or carbohydrate foods in obese women
-
Green S, Lawton C, Wales J, et al. Risk factors for overeating: dexfenfluramine suppresses the intake of sweet high fat or carbohydrate foods in obese women [abstract]. Int J Obes 1997; 21 Suppl. 2: s64
-
(1997)
Int J Obes
, vol.21
, Issue.2 SUPPL.
-
-
Green, S.1
Lawton, C.2
Wales, J.3
-
143
-
-
0030914304
-
The role of dietary fat in obesity
-
Golay A, Bobbioli E. The role of dietary fat in obesity. Int J Obes 1997; 21 (3 Suppl.): s2-11
-
(1997)
Int J Obes
, vol.21
, Issue.3 SUPPL.
-
-
Golay, A.1
Bobbioli, E.2
-
144
-
-
0026877323
-
Food preferences in human obesity: Carbohydrates verses fats
-
Drewnowski A, Kurth C, Holden-Wiltse J, et al. Food preferences in human obesity: carbohydrates verses fats. Appetite 1992; 18: 207-1
-
(1992)
Appetite
, vol.18
, pp. 207-211
-
-
Drewnowski, A.1
Kurth, C.2
Holden-Wiltse, J.3
-
145
-
-
9444287592
-
Appetite suppressant drugs and the risk of primary pulmonary hypertension
-
Abenhaim L, Moride Y, Benot F, et al. Appetite suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996; 335: 609-16
-
(1996)
N Engl J Med
, vol.335
, pp. 609-616
-
-
Abenhaim, L.1
Moride, Y.2
Benot, F.3
-
146
-
-
0030876952
-
Valvular heart disease associated with fenfluramine-phentermine
-
Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997; 337: 581-8
-
(1997)
N Engl J Med
, vol.337
, pp. 581-588
-
-
Connolly, H.M.1
Crary, J.L.2
McGoon, M.D.3
-
147
-
-
0030807425
-
Death from irreversible pulmonary hypertension associated with short-term use of fenfluramine and phentermine
-
Dillon KA, Putnam KG, Avorn JL. Death from irreversible pulmonary hypertension associated with short-term use of fenfluramine and phentermine [letter]. JAMA 1997; 278: 1320
-
(1997)
JAMA
, vol.278
, pp. 1320
-
-
Dillon, K.A.1
Putnam, K.G.2
Avorn, J.L.3
-
148
-
-
0030853476
-
Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine
-
Mark EJ, Patalas ED, Chang HT, et al. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine. N Engl J Med 1997; 337: 602-6
-
(1997)
N Engl J Med
, vol.337
, pp. 602-606
-
-
Mark, E.J.1
Patalas, E.D.2
Chang, H.T.3
-
149
-
-
7144265249
-
Health advisory on fenfluramine/phentermine for obesity
-
Aug 27
-
Food and Drug Administration. Health advisory on fenfluramine/phentermine for obesity. Media Release 1997 Aug 27
-
(1997)
Media Release
-
-
-
150
-
-
0030853477
-
Valvular heart disease associated with dexfenfluramine
-
Cannistra LV, Davis SM, Bouman AG. Valvular heart disease associated with dexfenfluramine [letter]. New Engl J Med 1997; 337: 636
-
(1997)
New Engl J Med
, vol.337
, pp. 636
-
-
Cannistra, L.V.1
Davis, S.M.2
Bouman, A.G.3
-
151
-
-
0031442220
-
High altitude may be synergistic with pulmonary hazards of appetite control medications fenfluramine and dexfenfluramine
-
Davis WM, Waters IW. High altitude may be synergistic with pulmonary hazards of appetite control medications fenfluramine and dexfenfluramine. Med Hypotheses 1997; 49: 509-12
-
(1997)
Med Hypotheses
, vol.49
, pp. 509-512
-
-
Davis, W.M.1
Waters, I.W.2
-
152
-
-
7144267316
-
Knoll Meridia blood pressure elevation screen should be created; BP concerns outweigh weight loss benefit for 39%-50% patients, FDA committee concludes
-
Sept 39
-
Knoll Meridia blood pressure elevation screen should be created; BP concerns outweigh weight loss benefit for 39%-50% patients, FDA committee concludes. F-D-C Pink Sheets 1996 Sept 39; 58: 10-1
-
(1996)
F-D-C Pink Sheets
, vol.58
, pp. 10-11
-
-
-
153
-
-
7144242697
-
Knoll's sibutramine rejected by US panel
-
Oct
-
Knoll's sibutramine rejected by US panel. Marketletter 1996 Oct 7: 18
-
(1996)
Marketletter
, vol.7
, pp. 18
-
-
-
154
-
-
10544251216
-
Eating patterns in obesity
-
Stunkard AJ. Eating patterns in obesity. Psychiatr Q 1959; 33: 284-92
-
(1959)
Psychiatr Q
, vol.33
, pp. 284-292
-
-
Stunkard, A.J.1
-
155
-
-
0026534579
-
Binge eating disorder: A multisite field study of the diagnostic criteria
-
Spitzer RL, Deslin M, Walsh BT, et al. Binge eating disorder: a multisite field study of the diagnostic criteria. Int J Eat Disord 1992; 11: 191-203
-
(1992)
Int J Eat Disord
, vol.11
, pp. 191-203
-
-
Spitzer, R.L.1
Deslin, M.2
Walsh, B.T.3
-
156
-
-
0027281085
-
Is migraine related to the eating disorders
-
Brewerton TD, George MS. Is migraine related to the eating disorders. Int J Eat Disord 1993; 14: 75-9
-
(1993)
Int J Eat Disord
, vol.14
, pp. 75-79
-
-
Brewerton, T.D.1
George, M.S.2
-
157
-
-
0026595339
-
Neuro-endocrine responses to m-chlorophenylypiperazine and l-tryptophan in bulimia
-
Brewerton TD, Mueller EA, Lesam MD, et al. Neuro-endocrine responses to m-chlorophenylypiperazine and l-tryptophan in bulimia. Arch Gen Psychiatry 1992; 49: 852-61
-
(1992)
Arch Gen Psychiatry
, vol.49
, pp. 852-861
-
-
Brewerton, T.D.1
Mueller, E.A.2
Lesam, M.D.3
-
158
-
-
0030271341
-
A direct measurement of satiety disturbance in patients with bulimia nervosa
-
Kissileff HR, Wentzlaff TH, Guss JL, et al. A direct measurement of satiety disturbance in patients with bulimia nervosa. Physiol Behav 1996; 60: 1077-85
-
(1996)
Physiol Behav
, vol.60
, pp. 1077-1085
-
-
Kissileff, H.R.1
Wentzlaff, T.H.2
Guss, J.L.3
-
160
-
-
0025614587
-
The fluoxetine treatment of low weight, chronic bulimia nervosa
-
Solyom L, Solyom C, Ledwidge B. The fluoxetine treatment of low weight, chronic bulimia nervosa. J Clin Psychopharmacol 1990; 10: 421-5
-
(1990)
J Clin Psychopharmacol
, vol.10
, pp. 421-425
-
-
Solyom, L.1
Solyom, C.2
Ledwidge, B.3
-
161
-
-
0027372562
-
Pharmacotherapy of bulimia nervosa - Experience with fluoxetine
-
Wood A. Pharmacotherapy of bulimia nervosa - experience with fluoxetine. Int Clin Psychopharmacol 1993; 8 (4): 245-9
-
(1993)
Int Clin Psychopharmacol
, vol.8
, Issue.4
, pp. 245-249
-
-
Wood, A.1
-
162
-
-
0029063763
-
Long-term fluoxetine treatment of bulimia nervosa
-
Goldstein DJ, Wilson MG, Thompson VL, et al., Fluoxetine Bulimia Nervosa Research Group. Long-term fluoxetine treatment of bulimia nervosa. Br J Psychiatrv 1995; 166: 660-6
-
(1995)
Br J Psychiatrv
, vol.166
, pp. 660-666
-
-
Goldstein, D.J.1
Wilson, M.G.2
Thompson, V.L.3
-
165
-
-
0024314682
-
Treatment of bulimia nervosa with trazodone: Short-term response and long-term follow-up
-
Hudson JL, Pope Jr HG, Keck Jr PE, et al. Treatment of bulimia nervosa with trazodone: short-term response and long-term follow-up. Clin Neuropharmacol 1989; 12 (1 Suppl.): s38-46
-
(1989)
Clin Neuropharmacol
, vol.12
, Issue.1 SUPPL.
-
-
Hudson, J.L.1
Pope Jr., H.G.2
Keck Jr., P.E.3
-
167
-
-
0029957925
-
D-fenfluramine treatment of binge eating disorder
-
Stunkard A, Berkowitz R, Tratikut C, et al. D-fenfluramine treatment of binge eating disorder. Am J Psychiatr 1996; 153: 1455-9
-
(1996)
Am J Psychiatr
, vol.153
, pp. 1455-1459
-
-
Stunkard, A.1
Berkowitz, R.2
Tratikut, C.3
-
168
-
-
0029825108
-
A double-blind, placebo-controlled trial of the effect of fluoxetine on dietary intake in overweight women with and without binge-eating disorder
-
Greno CA, Wing R. A double-blind, placebo-controlled trial of the effect of fluoxetine on dietary intake in overweight women with and without binge-eating disorder. Am J Clin Nutr 1996; 64: 267-73
-
(1996)
Am J Clin Nutr
, vol.64
, pp. 267-273
-
-
Greno, C.A.1
Wing, R.2
-
169
-
-
0027232955
-
A placebo-controlled trial of d-fenfluramine in bulimia nervosa
-
Fahy TA, Elsler I, Russell GP. A placebo-controlled trial of d-fenfluramine in bulimia nervosa. Br J Psychiatry 1993; 162: 597-603
-
(1993)
Br J Psychiatry
, vol.162
, pp. 597-603
-
-
Fahy, T.A.1
Elsler, I.2
Russell, G.P.3
|